A synthetic single-chain porcine insulin precursor (PIP) gene and an α-mating factor leader sequence (αMFL) gene obtained by the PCR method are inserted between the promoter and 3’-terminating sequence of the alcoh...A synthetic single-chain porcine insulin precursor (PIP) gene and an α-mating factor leader sequence (αMFL) gene obtained by the PCR method are inserted between the promoter and 3’-terminating sequence of the alcohol dehydrogenase gene ADH1 in plasmid pVT102-U to form plasmid pVT102-U/α MFL-PIP. The single-chain insulin precursor is expressed and secreted to the culture medium by Saccharomyces cererisiae transformed by pVT102-U/αMFL-PIP. The precursor is purified and converted into human insulin by tryptic transpeptidation. The purified human insulin is fully active and can be crystallized. The overall yield of human insulin is 25 mg per liter of culture medium.展开更多
研究了基因工程菌P ich ia p astotis高密度、高表达的培养条件。在全合成摇瓶培养基的基础上,考察了诱导过程中甲醇浓度、温度、pH、(NH4)2SO4及磷酸盐浓度等因素对猪胰岛素前体(P IP)表达的影响。研究表明:甲醇的最佳诱导浓度为6 g/L...研究了基因工程菌P ich ia p astotis高密度、高表达的培养条件。在全合成摇瓶培养基的基础上,考察了诱导过程中甲醇浓度、温度、pH、(NH4)2SO4及磷酸盐浓度等因素对猪胰岛素前体(P IP)表达的影响。研究表明:甲醇的最佳诱导浓度为6 g/L,过高或过低的甲醇浓度都不利于菌体生长和蛋白表达;在菌体生长和蛋白表达阶段,pH应分别控制在5.5和4.0;诱导阶段,培养温度下降到28°C,可以提高重组蛋白质的表达量。上述结果用于15 L全自动发酵罐实验,P IP表达水平达到了1.69 g/L,是摇瓶结果的17倍。展开更多
合成含短C肽AAK,并去掉B链第30位苏氨酸(T)的人胰岛素原类似物:HMPIDesB30(human mini-proinsulin des B30)的cDNA,将其插入大肠杆菌和酵母菌的穿梭质粒pPIC9K.用电转移的方法将重组质粒HMPIDesB30/pPIC9K转入甲醇酵母GS115.用含不同G41...合成含短C肽AAK,并去掉B链第30位苏氨酸(T)的人胰岛素原类似物:HMPIDesB30(human mini-proinsulin des B30)的cDNA,将其插入大肠杆菌和酵母菌的穿梭质粒pPIC9K.用电转移的方法将重组质粒HMPIDesB30/pPIC9K转入甲醇酵母GS115.用含不同G418浓度的YPD平板筛选高拷贝重组子.经优化条件下的高密度发酵,发酵液用SIPI-40大孔树脂吸附,大孔吸附树脂洗脱液经SP柱进一步纯化后,再用10～20mmol/L Zn2+沉淀,能得到纯度为95%的HMPIDesB30.通过16.5%Tricine SDS-PAGE、HPLC和质谱分析,表达产物分子质量与理论分子质量相符,经高密度发酵,表达量可达1.0g/L.纯化回收率可达60%.说明人胰岛素原类似物HMPIDesB30能在甲醇酵母中高效分泌表达,并能通过经济有效的方法纯化.展开更多
Insulin controls hyperglycemia caused by diabetes,and virtually all treatments require exogenous insulin. The monomeric B27 Lys destripeptide insulin has 80% bioactivity of wild type. It is a potential drug for clinic...Insulin controls hyperglycemia caused by diabetes,and virtually all treatments require exogenous insulin. The monomeric B27 Lys destripeptide insulin has 80% bioactivity of wild type. It is a potential drug for clinic. But the yield of monomeric B27 Lys destripeptide insulin is limited, because monomeric B27 Lys destripeptide insulin precursor( MIP) was easily to form inclusion body,when MIP is expressed in E. coli. The precursor,MIP,is not only fused to an N-terminal HIS-small ubiquitin-related modifier( SUMO) tag,but also added five Arginine( 5 R) at the C-terminal,which can improve the solubility of the fusion protein. By this way,the yield of fusion protein has been up to 1. 45 mg/L cell culture.This work set up the foundation for the clinical application of B27 Lys destripeptide insulin.展开更多
基金Project supported by the National High Technology Program of China.
文摘A synthetic single-chain porcine insulin precursor (PIP) gene and an α-mating factor leader sequence (αMFL) gene obtained by the PCR method are inserted between the promoter and 3’-terminating sequence of the alcohol dehydrogenase gene ADH1 in plasmid pVT102-U to form plasmid pVT102-U/α MFL-PIP. The single-chain insulin precursor is expressed and secreted to the culture medium by Saccharomyces cererisiae transformed by pVT102-U/αMFL-PIP. The precursor is purified and converted into human insulin by tryptic transpeptidation. The purified human insulin is fully active and can be crystallized. The overall yield of human insulin is 25 mg per liter of culture medium.
文摘研究了基因工程菌P ich ia p astotis高密度、高表达的培养条件。在全合成摇瓶培养基的基础上,考察了诱导过程中甲醇浓度、温度、pH、(NH4)2SO4及磷酸盐浓度等因素对猪胰岛素前体(P IP)表达的影响。研究表明:甲醇的最佳诱导浓度为6 g/L,过高或过低的甲醇浓度都不利于菌体生长和蛋白表达;在菌体生长和蛋白表达阶段,pH应分别控制在5.5和4.0;诱导阶段,培养温度下降到28°C,可以提高重组蛋白质的表达量。上述结果用于15 L全自动发酵罐实验,P IP表达水平达到了1.69 g/L,是摇瓶结果的17倍。
基金China Postdoctoral Science Foundation Projects(No.2015M571455)National Undergraduate Training Program for Innovation and Entrepreneurship,China(No.17T10509)
文摘Insulin controls hyperglycemia caused by diabetes,and virtually all treatments require exogenous insulin. The monomeric B27 Lys destripeptide insulin has 80% bioactivity of wild type. It is a potential drug for clinic. But the yield of monomeric B27 Lys destripeptide insulin is limited, because monomeric B27 Lys destripeptide insulin precursor( MIP) was easily to form inclusion body,when MIP is expressed in E. coli. The precursor,MIP,is not only fused to an N-terminal HIS-small ubiquitin-related modifier( SUMO) tag,but also added five Arginine( 5 R) at the C-terminal,which can improve the solubility of the fusion protein. By this way,the yield of fusion protein has been up to 1. 45 mg/L cell culture.This work set up the foundation for the clinical application of B27 Lys destripeptide insulin.
